Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex
Cell Metabolism · 2025-03 · 37 (3) · 692-707.e9
DOI: 10.1016/j.cmet.2024.09.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2025-03. Verfasst von Chenxi Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Med…. Hauptthemen laut MEDLINE: Obesity, Glutathione, Breast Neoplasms, Mechanistic Target of Rapamycin Complex 1. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Chinese Academy of Meteorological Sciences.
Abstract (Originalsprache)
Obesity is a major risk factor for poor breast cancer outcomes, but the impact of obesity-induced tumor microenvironment (TME) metabolites on breast cancer growth and metastasis remains unclear. Here, we performed TME metabolomic analysis in high-fat diet (HFD) mouse models and found that glutathione (GSH) levels were elevated in the TME of obesity-accelerated breast cancer. The deletion of glutamate-cysteine ligase catalytic subunit (GCLC), the rate-limiting enzyme in GSH biosynthesis, in adipocytes but not tumor cells reduced obesity-related tumor progression. Mechanistically, we identified that GSH entered tumor cells and directly bound to lysosomal integral membrane protein-2 (scavenger receptor class B, member 2 [SCARB2]), interfering with the interaction between its N and C termini. This, in turn, recruited mTORC1 to lysosomes through ARF1, leading to the activation of mTOR signaling. Overall, we demonstrated that GSH links obesity and breast cancer progression by acting as an activator of mTOR signaling. Targeting the GSH/SCARB2/mTOR axis could benefit breast cancer patients with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking U…
- Department of Breast Surgery, The First Affiliated Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang 110001, Liaoning, China.
- Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, D…
- Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China; Cancer Center, Tongji University School of Medicine, Shanghai 200331, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chinese Academy of Meteorological Sciences
Zitieren
APA
Zhao, C., Zhang, T., Xue, S. T., Zhang, P., Wang, F., Li, Y., Liu, Y., Zhao, L., Wu, J., Yan, Y., Mao, X., Chen, Y., Yuan, J., Li, Z., & Li, K. (2025). Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex. Cell Metabolism, 37(3), 692-707.e9. https://doi.org/10.1016/j.cmet.2024.09.013
Vancouver
Zhao C, Zhang T, Xue ST, Zhang P, Wang F, Li Y, et al. Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex. Cell Metabolism. 2025;37(3):692-707.e9. doi:10.1016/j.cmet.2024.09.013
BibTeX
@article{Zhao2025,
author = {Zhao, Chenxi and Zhang, Tingting and Xue, Si-Tu and Zhang, Peitao and Wang, Feng and Li, Yunxuan and Liu, Ying and Zhao, Luyao and Wu, Jie and Yan, Yechao and Mao, Xiaoyun and Chen, Yuping and Yuan, Jian and Li, Zhuorong and Li, Ke},
title = {Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex},
journal = {Cell Metabolism},
year = {2025},
volume = {37},
number = {3},
pages = {692--707.e9},
doi = {10.1016/j.cmet.2024.09.013}
}
EUVIMED